Next-Generation Multi-Agonist Peptides The progression from GLP-1 mono-agonists (semaglutide, liraglutide) to GLP-1/GIP dual agonists (tirzepatide) to triple agonists (retatrutide: GLP-1/GIP/glucagon, Lilly Phase 3) represents a systematic intensification of multi-receptor engagement to drive superior metabolic outcomes
GLP 1 weight loss works by acting on multiple systems in the body: Slows gastric emptying, helping you feel full for longer Reduces appetite and food cravings Improves insulin sensitivity and blood sugar control Supports steady and sustainable fat loss Because GLP 1 weight loss works at a metabolic level, results are often more consistent and maintainable when combined with medical supervision and lifestyle guidance
It can also reduce the chance of developing conditions such as type 2 diabetes and heart disease
Reduces Not Burns Belly Fat While semaglutide is highly effective at reducing unwanted belly fat, its essential for patients to understand that it is not a belly fat burner
Benefits Synergistic Brightening Shield: Formulated with a potent blend of Glutathione and Niacinamide to protect the skin from environmental stressors while delivering a continuous boost of radiance for a clear, luminous complexion all day long